Microporous zirconium silicate for the treatment of hyperkalemia
AssigneeZs Pharma, Inc.
InventorsDonald Jeffrey Keyser, Alvaro F. Guillem
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
Claims22
A method of removing excess potassium ions and ammonium ions comprising administering to a subject in need thereof a composition comprising a zirconium silicate particle of formula (I):
- ApMxZr1-xSinGeyOm (I)
- where A is a potassium ion, sodium ion, rubidium, ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, M is at least one framework metal, wherein the framework metal is hafnium (4+), tin (4+), niobium (5+), titanium (4+), cerium (4+), germanium (4+), praseodymium (4+), terbium (4+) or mixtures thereof, “p” has a value from about 1 to about 20, “x” has a value from 0 to less than 1, “n” has a value from about 0 to about 12, “y” has a value from 0 to about 12, “m” has a value from about 3 to about 36 and 1≦n+y≦12,
- wherein the zirconium silicate particles are in a form of ZS-1, ZS-2, ZS-6, ZS-7, ZS-8, ZS-9, or ZS-11 that exhibit a uniform microporous structure and have median particle size of greater than 3 microns and less than 7% of the particles in the composition have a diameter less than 3 microns, and the composition exhibits a sodium content below 12% by weight.
Dependencies are inferred from the claim text.